Jump to content

Piperacetazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by ByVarying (talk | contribs) at 03:35, 20 June 2022 (→References: Categorization). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Piperacetazine
Clinical data
AHFS/Drugs.comInternational Drug Names
Identifiers
  • 1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.021.194 Edit this at Wikidata
Chemical and physical data
FormulaC24H30N2O2S
Molar mass410.58 g·mol−1
3D model (JSmol)
  • CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CCO)CC4)c2c1
  • InChI=InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3
  • Key:BTFMCMVEUCGQDX-UHFFFAOYSA-N

Piperacetazine (Quide) is an antipsychotic prodrug, most notably used for schizophrenia.[1] It is a phenothiazine derivative.

References

  1. ^ Rada RT, Donlon PT (February 1974). "Piperacetazine in ambulatory chronic schizophrenic patients". Current Therapeutic Research, Clinical and Experimental. 16 (2): 124–9. PMID 4156665.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Piperacetazine&oldid=1093992224"